Skip to main content
Premium Trial:

Request an Annual Quote

Quark Biotech and Fujisawa Pharmaceutical Extend Collaboration

NEW YORK, Aug. 6 (GenomeWeb News) - Quark Biotech of Fremont, Calif., and Fujisawa Pharmaceutical of Japan have extended their drug discovery collaboration for an additional year, the companies said today.


The two companies allied on stroke research in 1999, utilizing Quark's high-throughput technology to explore gene and protein functions relating to stroke, screening genes, and devising bioassays to screen small molecule libraries.


Financial details were not provided.

The Scan

Team Tracks Down Potential Blood Plasma Markers Linked to Heart Failure in Atrial Fibrillation Patients

Researchers in BMC Genomics found 10 differentially expressed proteins or metabolites that marked atrial fibrillation with heart failure cases.

Study Points to Synonymous Mutation Effects on E. Coli Enzyme Activity

Researchers in Nature Chemistry saw signs of enzyme activity shifts in the presence of synonymous mutations in a multiscale modeling analysis of three Escherichia coli genes.

Team Outlines Paternal Sample-Free Single-Gene Approach for Non-Invasive Prenatal Screening

With data for nearly 9,200 pregnant individuals, researchers in Genetics in Medicine demonstrate the feasibility of their carrier screening and reflex single-gene non-invasive prenatal screening approach.

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.